Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. (2014)
Attributed to:
Enhanced Mass Spectrometry Facilities for the Astbury Centre for Structural Molecular Biology
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/ja406831n
PubMed Identifier: 24372466
Publication URI: http://europepmc.org/abstract/MED/24372466
Type: Journal Article/Review
Volume: 136
Parent Publication: Journal of the American Chemical Society
Issue: 2
ISSN: 0002-7863